Market research
LCT.AU Living Cell Technologies Limited
AU AUD Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the LCT.AU discussion.
5 years, 5 months ago
Living Cell Technologies Limited is currently in a long term uptrend where the price is trading 3.9% above its 200 day moving average.
From a valuation standpoint, the stock is 1371.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 3788.0.
Living Cell Technologies Limited's total revenue sank by 55.6% to $120K since the same quarter in the previous year.
Its net income has dropped by 184.7% to $-643K since the same quarter in the previous year.
Finally, its free cash flow grew by 74.6% to $-313K since the same quarter in the previous year.
Based on the above factors, Living Cell Technologies Limited gets an overall score of 2/5.